DCF — MARTHAS VINEYARD HOSPITAL
Enterprise Value: $16.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$16.5M
Enterprise Value
$1.7M
PV of Cash Flows
$14.8M
PV of Terminal Value
$23.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $125.2M | $4.6M | 4.0% | $-1.0M | $-0.9M |
| Year 2 | $129.0M | $6.1M | 5.0% | $-0.1M | $-0.1M |
| Year 3 | $132.9M | $7.6M | 6.0% | $0.9M | $0.7M |
| Year 4 | $136.9M | $8.5M | 6.0% | $1.4M | $1.0M |
| Year 5 | $141.0M | $9.1M | 6.0% | $1.7M | $1.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $16.5M. Terminal value accounts for 90% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$121.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.03207691912509373
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5